Natural Fungal Fermentation Broth of Scleroderma bovista Ameliorates Ulcerative Colitis by Suppressing the NF-κB Pathway and Gut Microbial Dysbiosis
Year: 2026
Type: article
Abstract: Scleroderma bovista fermentation broth (SBF) exhibits anti-inflammatory activity, but its effect on ulcerative colitis (UC) remains unclear. LC-MS/MS analysis revealed that SBF contains 43 compounds, including sclerocitrin homologs, cyclic peptides, and alkaloids. In vitro, SBF (20–40 μg/mL) promoted cell viability in LPS-stimulated RAW264.7 macrophages, suppressed nitric oxide overproduction, reduced iNOS, IL-1β, and COX-2 expression, and upregulated IL-10 mRNA expression. In vivo, in a dextran sulfate sodium (DSS)-induced colitis model, SBF (50–200 mg/kg) dose-dependently mitigated DSS-induced weight loss, disease activity, splenomegaly, colon shortening, crypt damage, and representative images suggested a reduction in macrophage infiltration. The highest dose (SBF200) showed efficacy comparable to that of 5-ASA. Mechanistically, SBF reduced colonic IL-1β, TNF-α, and IL-6 levels and inhibited NF-κB activation by decreasing phosphorylated IκBα and p65. Colonic IL-10, which was elevated in DSS-treated mice, was lower in SBF groups than in the 5-ASA group. Furthermore, 16S rRNA sequencing showed that SBF lowered the DSS-elevated Shannon index and shifted the PCoA profiles of colitic mice toward the control group. At the genus level, SBF treatment further enriched Akkermansia (already elevated in DSS mice compared with controls) and increased Faecalibaculum, while reducing the relative abundance of Turicibacter, Clostridium, and Enterococcus; Ligilactobacillus was only partially restored and remained below control levels. Thus, SBF prophylactically mitigates DSS-induced colitis by suppressing inflammation, inhibiting NF-κB signaling, and modulating the gut microbiota, supporting further investigation of SBF as a potential fungal-derived candidate for UC treatment.
Source: Microorganisms
Authors: Ying Yang(Data curation, Validation, Writing – original draft), Min Zhang(Conceptualization, Investigation, Methodology), Xinnuo Li(Investigation, Software), Yunqing Cheng(Conceptualization, Data curation, Methodology), Siqi Yang(Formal analysis, Investigation, Software), Hongli He(Project administration, Resources, Supervision), Xianjun Feng(Investigation, Resources, Supervision), Jianfeng Liu(Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing – review & editing)
Institution: Jilin Normal University
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
Award: G9001397323
OpenAlex ID: W7236204616
